Rare diseases
Investigational molecules
Locations
Back to France587 clinical trials in Vandoeuvre Les Nancy, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceLong-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis
FranceStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
FranceStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
FranceStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
FranceStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
FranceStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
FranceStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
FranceA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancer types, including head and neck squamous cell carcinoma, multiple myeloma, and prostate cancer. Studies evaluate new therapeutic approaches and diagnostic methods.
Several trials investigate novel drug combinations and targeted therapies for improving patient outcomes.
Comprehensive research into inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Studies explore innovative treatments including microbiota transplantation and new biological therapies.
Trials aim to develop more effective maintenance therapies and improve quality of life for patients.
Groundbreaking research in multiple sclerosis treatment, including both progressive and relapsing forms. Studies evaluate new therapeutic approaches and disease progression markers.
Focus on developing innovative treatments for better management of neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
